Dialysis Access Treatment Devices | Market Insights | Asia Pacific (Supplemental) | 2022
Although the COVID-19 pandemic has had a short-term negative impact on the Asia Pacific dialysis access treatment device market, the dynamic nature of the market, the launch of novel and innovative premium-price products backed by clinical data, increasing patient access to dialysis care, and improvement in reimbursement will lead to steady growth through the remainder of the forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints in the region.
This Medtech 360 Report provides high-level market metrics for dialysis access treatment devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across an 11-year period.
